Whether its pounds lost or improved blood sugar levels, the benefits of Semaglutide will begin to shine
Choosing between weight loss medications can feel overwhelming, especially when options work through entirely different mechanisms
RNA analysis mRNA was isolated from cells or tissues using an E.Z.N.A
Weight management after gallbladder removal presents a distinct challenge: altered lipid absorption, increased diarrhea risk, and potential medication intolerance complicate treatment selection
Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
